Citation: | Guo Linlang, Guo Ying, Cao Changan. Significance of HLA-DR, Fas, bcl-2 and bax Expression in Hepatocellular Carcionma[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 94-95. |
[1] |
郭琳琅,曹长安.HLA-Dh抗原在大肠癌良恶性病变中的表达.第一军医大学学报,1995 15 (4): 327.
|
[2] |
刘保安,粟占之,陈森林,等.鼻咽癌细胞人自细胞Dh抗原表达及其与临床病理和预后的关系.中华病理学杂志,1996, 25(3):163.
|
[3] |
Hamazaki K, Gochi A, Matsubarn N, et al.Expmssion of Fas antigen and bcl-2 pmtein in hepatncellular carcinoma Acta-Med-Okayama,1995, 49(4): 227.
|
[4] |
王万忠,王家耀,杜德利.bcl-2癌基因在肝肿瘤表达.中华医学杂患.1996.76(6):470.
|
[5] |
Charlotte F, L Hemnine A,Martin N, et al.lmmunohistochemical detection ofbcl-2protein in mrmal and patholocal human liver.Am J Pathol 1994,144:460.
|
[6] |
朱锡华.Fas系统研究进展.16(2):77.
|
[7] |
郑勇,袁泉.细胞凋亡基因Fas的研究进展.国外医学免疫学分册,1996, 17(3):131.
|
[8] |
Oltvai ZN, Milkman C L and Korsmever S,J. Bcl-2 heterodimerizes in vivo with a conwrved homolog Bax that accelerates programmmed cell death Cell 1993, 74:609.
|
[9] |
Wyliiea All. Death get a brake.Nature,1994,369:272.
|